Unknown

Dataset Information

0

Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2ctd of Clostridioides difficile.


ABSTRACT: Clostridioides difficile, formerly known as Clostridium difficile, is a spore-forming bacterium considered as the most common cause of nosocomial infections in developed countries. The spore of C. difficile is involved in the transmission of the pathogen and in its first interaction with the host; therefore, a therapeutic approach able to control C. difficile spores would improve the clearance of the infection. The C-terminal (CTD) end of BclA2, a spore surface protein of C. difficile responsible of the interaction with the host intestinal cells, was selected as a putative mucosal antigen. The BclA2 fragment, BclA2CTD, was purified and used to nasally immunize mice both as a free protein and after adsorption to the spore of Bacillus subtilis, a well-established mucosal delivery vehicle. While the adsorption to spores increased the in vitro stability of BclA2CTD, in vivo both free and spore-adsorbed BclA2CTD were able to induce a similar, specific humoral immune response in a murine model. Although in the experimental conditions utilized the immune response was not protective, the induction of specific IgG indicates that free or spore-bound BclA2CTD could act as a putative mucosal antigen targeting C. difficile spores.

SUBMITTER: Maia AR 

PROVIDER: S-EPMC7072882 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2<sub>ctd</sub> of <i>Clostridioides difficile</i>.

Maia Ana Raquel AR   Reyes-Ramírez Rodrigo R   Pizarro-Guajardo Marjorie M   Saggese Anella A   Castro-Córdova Pablo P   Isticato Rachele R   Ricca Ezio E   Paredes-Sabja Daniel D   Baccigalupi Loredana L  

International journal of molecular sciences 20200214 4


<i>Clostridioides difficile</i>, formerly known as <i>Clostridium difficile</i>, is a spore-forming bacterium considered as the most common cause of nosocomial infections in developed countries. The spore of <i>C. difficile</i> is involved in the transmission of the pathogen and in its first interaction with the host; therefore, a therapeutic approach able to control <i>C. difficile</i> spores would improve the clearance of the infection. The C-terminal (CTD) end of BclA2, a spore surface protei  ...[more]

Similar Datasets

| S-EPMC8271131 | biostudies-literature
| S-EPMC8111532 | biostudies-literature
2022-04-09 | GSE200346 | GEO
| S-EPMC8724541 | biostudies-literature
| S-EPMC8025294 | biostudies-literature
| S-EPMC8204484 | biostudies-literature
| S-EPMC6867894 | biostudies-literature
2019-01-15 | GSE120189 | GEO
2022-09-17 | GSE165751 | GEO
2019-10-24 | GSE135912 | GEO